Minnesota has reported a presumptive case of monkeypox, an infectious disease that has raised concerns because it emerged globally this spring and has been found in 26 U.S. states.
The infection announced Monday involves a Twin Cities man who is receiving outpatient treatment for an infection that likely occurred during travel to Europe. The state's public health laboratory identified the infection on Saturday night with a positive test result, which is being confirmed by the Centers for Disease Control and Prevention.
The man did not appear to have close contacts in Minnesota that present high risks of spreading the virus to others, said Dr. Ruth Lynfield, state epidemiologist and medical director of the Minnesota Department of Health.
The risk to the broader public is low because the monkeypox virus doesn't spread as easily as other infectious agents that cause measles, influenza or COVID-19. Transmission often involves prolonged face-to-face exposure or contact with infectious sores or bodily fluids, or with contaminated clothing or other items.
"It's important that everyone be aware of this disease, so that those at risk can seek medical care and get tested promptly if they believe they have symptoms," said Minnesota Health Commissioner Jan Malcolm.
The CDC has identified more than 200 monkeypox cases in 26 states. Common symptoms include fever, fatigue, headaches, muscle aches, swollen lymph nodes and a rash that can look like pimples or blisters. Some people in the outbreak have only reported rashes, which typically are found on the hands, feet, face or genitals.
Antiviral treatments and vaccines are available but are used on a case-by-case basis. The CDC recommends monkeypox vaccine in advance of exposure only to health care workers and researchers who work with the virus.
People with monkeypox are considered infectious until their rashes have healed. Typical illnesses last two to four weeks. Rare cases can cause pneumonia or be fatal.